U.S. pharmaceutical company
Johnson & Johnson pauses COVID-19 vaccine trial over patient illness
U.S. pharmaceutical company Johnson & Johnson said Monday it had paused its COVID-19 vaccine trial because one of its participants had become sick.
4 years ago